Clinical Trial: Study on Biomarkers of Immune-Related Adverse Events

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527585) titled 'Study on Biomarkers of Immune-Related Adverse Events' on April 07.

Brief Summary: 1. To identify biomarkers of immune-related adverse events;

2. To develop a predictive model for immune-related adverse events.

Study Start Date: April, 2026

Study Type: OBSERVATIONAL

Condition: Immune-Related Adverse Events

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Huazhong University of Science and Technology

Information provided by (Responsible Party): Xianglin Yuan, Tongji Hospital

Published by HT Digital Content Services with permission from Health Daily Digest....